A PHASE III, INTERNATIONAL, MULTICENTER, RANDOMISED OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBINUTUZUMAB VERSUS MMF IN PATIENTS WITH CHILDHOOD ONSET IDIOPATHIC NEPHROTIC SYNDROME"
Clinical Trial Grant
Administered By
Pediatrics, Nephrology
Awarded By
Genentech, Inc.
Start Date
October 19, 2023
End Date
December 11, 2025
Administered By
Pediatrics, Nephrology
Awarded By
Genentech, Inc.
Start Date
October 19, 2023
End Date
December 11, 2025